Literature DB >> 2020765

Pathophysiological approaches to identifying tumor hypoxia in patients.

W Mueller-Klieser1, K H Schlenger, S Walenta, M Gross, U Karbach, M Hoeckel, P Vaupel.   

Abstract

The present report summarizes observations of the authors on tumor oxygenation and on techniques for characterizing tumor hypoxia in patients. Cryospectrophotometric measurements of HbO2 saturations in tumor microvessels allow for estimates of the proportion of well oxygenated tissue regions. Labeling of tissue areas at oxygen (O2) tensions (pO2) less than 10 mm Hg with misonidazole may be used for a general characterization of the oxygenation status in patient tumors rather than for the determination of the radiobiologically hypoxic cell fraction. Quantitative bioluminescence and single photon imaging make it possible to determine ATP concentrations in absolute terms with a spatial resolution at the cellular level. It is shown that the ATP distribution reflects the efficiency of the O2 supply to tumors. Since all these techniques rely on biopsy material, the measured values can be assessed in relation to the histological structure and vascular pattern of the tumors. Such a direct interrelationship is not obtained when using polarographic microelectrodes in tumor tissue. However, a novel technology, the "computerized pO2 histography" has enabled direct polarographic measurements of pO2 values in patients, in extended and systematic clinical trials. Preliminary results in cervix and breast cancers demonstrate that pO2 values are lower in tumors than in adjacent normal tissues, and that great intra- and intertumoral differences occur even among tumors of the same clinical stages and histological grades, illustrating the necessity of such a pathophysiological approach to an "individualization" of tumor therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2020765     DOI: 10.1016/0167-8140(91)90182-g

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

1.  Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes.

Authors:  Christian Reinke; Shannon Bevans-Fonti; Luciano F Drager; Mi-Kyung Shin; Vsevolod Y Polotsky
Journal:  J Appl Physiol (1985)       Date:  2011-07-07

2.  FDG--a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer.

Authors:  Michael Zimny; Bernd Gagel; Ercole DiMartino; Kurt Hamacher; Heinz H Coenen; Martin Westhofen; Michael Eble; Ulrich Buell; Patrick Reinartz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-14       Impact factor: 9.236

3.  The relationship between tumour oxygenation determined by oxygen electrode measurements and magnetic resonance spectroscopy of the fluorinated 2-nitroimidazole SR-4554.

Authors:  E O Aboagye; R J Maxwell; M R Horsman; A D Lewis; P Workman; M Tracy; J R Griffiths
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

4.  A prospective clinical study of ¹⁸F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy.

Authors:  Stéphanie Servagi-Vernat; Sarah Differding; Francois-Xavier Hanin; Daniel Labar; Anne Bol; John A Lee; Vincent Grégoire
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-26       Impact factor: 9.236

5.  Diagnosis of breast cancer using fluorescence and diffuse reflectance spectroscopy: a Monte-Carlo-model-based approach.

Authors:  Changfang Zhu; Gregory M Palmer; Tara M Breslin; Josephine Harter; Nirmala Ramanujam
Journal:  J Biomed Opt       Date:  2008 May-Jun       Impact factor: 3.170

Review 6.  Novel imaging approaches to head and neck cancer.

Authors:  Kenneth A Krohn; Bevan Yeuh
Journal:  Semin Oncol       Date:  2008-06       Impact factor: 4.929

7.  Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.

Authors:  Veerle Kersemans; Bart Cornelissen; Rebekka Hueting; Matthew Tredwell; Kamila Hussien; Philip D Allen; Nadia Falzone; Sally A Hill; Jonathan R Dilworth; Veronique Gouverneur; Ruth J Muschel; Sean C Smart
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

8.  Oxygen dependence of the cytotoxicity and metabolic activation of 4-alkylamino-5-nitroquinoline bioreductive drugs.

Authors:  B G Siim; G J Atwell; W R Wilson
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

9.  Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro.

Authors:  B G Siim; P L van Zijl; J M Brown
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

10.  Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver.

Authors:  G E Arteel; R G Thurman; J M Yates; J A Raleigh
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.